BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$18.64

Market cap

$6.62B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.46

Enterprise value

$28.98B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.bauschhealth.com

Highlights

Bausch Health Companies's quick ratio has increased by 14% from the previous quarter and by 14% YoY
The net income has grown by 6% from the previous quarter
The company's equity has shrunk by 76% YoY but it rose by 24% QoQ
BHC's gross profit is down by 6% year-on-year
The revenue has declined by 5% year-on-year

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
355.15M
Market cap
$6.62B
Enterprise value
$28.98B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.27
Price to sales (P/S)
0.82
EV/EBIT
N/A
EV/EBITDA
20.32
EV/Sales
3.6
Earnings
Revenue
$8.04B
EBIT
-$463M
EBITDA
$1.43B
Free cash flow
$641M
Per share
EPS
-$5.46
Free cash flow per share
$1.8
Book value per share
$1.65
Revenue per share
$22.6
TBVPS
$26.66
Balance sheet
Total assets
$31.56B
Total liabilities
$30.91B
Debt
$24.34B
Equity
$587M
Working capital
$939M
Liquidity
Debt to equity
41.47
Current ratio
1.2
Quick ratio
0.79
Net debt/EBITDA
15.68
Margins
EBITDA margin
17.7%
Gross margin
72.1%
Net margin
-23.9%
Operating margin
-4.9%
Efficiency
Return on assets
-6%
Return on equity
-270.6%
Return on invested capital
-1.7%
Return on capital employed
-1.7%
Return on sales
-5.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
0.38%
1 week
-3.12%
1 month
12.97%
1 year
-33.99%
YTD
-37.7%
QTD
19.95%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.04B
Gross profit
$5.8B
Operating income
-$393M
Net income
-$1.92B
Gross margin
72.1%
Net margin
-23.9%
The operating margin has plunged by 146% YoY but it has grown by 23% from the previous quarter
The company's operating income has shrunk by 144% YoY but it rose by 25% QoQ
BHC's gross profit is down by 6% year-on-year
The net income has grown by 6% from the previous quarter

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
11.27
P/S
0.82
EV/EBIT
N/A
EV/EBITDA
20.32
EV/Sales
3.6
BHC's EPS is up by 6% since the previous quarter
BHC's P/B is 197% above its 5-year quarterly average of 3.8 and 10% above its last 4 quarters average of 10.2
The company's equity has shrunk by 76% YoY but it rose by 24% QoQ
The price to sales (P/S) is 9% lower than the 5-year quarterly average of 0.9 but 2.5% higher than the last 4 quarters average of 0.8
The revenue has declined by 5% year-on-year

Efficiency

How efficient is Bausch Health Companies business performance
BHC's return on sales has dropped by 159% year-on-year but it is up by 18% since the previous quarter
BHC's return on invested capital has dropped by 155% year-on-year but it is up by 19% since the previous quarter
The ROE has plunged by 57% from the previous quarter
The ROA has grown by 4.8% from the previous quarter

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
Bausch Health Companies's total assets is 2.1% higher than its total liabilities
Bausch Health Companies's quick ratio has increased by 14% from the previous quarter and by 14% YoY
The current ratio has grown by 7% from the previous quarter and by 4.3% YoY
The company's equity has shrunk by 76% YoY but it rose by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.